Can RSO and Cannabinoids Reduce Cancer Tumors?

What Researchers Have Observed in the Laboratory

Over the past two decades, scientists have studied THC, CBD, and other cannabinoids in hundreds of laboratory experiments involving cancer cells.

Depending on the type of cancer and the cannabinoid studied, researchers have observed several potentially beneficial effects.

1. Triggering Cancer Cell Death (Apoptosis)

Healthy cells naturally die when they become damaged. Cancer cells often lose this ability, allowing them to multiply uncontrollably.

In laboratory studies, THC and CBD have been shown to activate signaling pathways that can trigger apoptosis in certain cancer cell lines. This means the cannabinoids encourage damaged cancer cells to self-destruct while having less effect on many healthy cells under experimental conditions.

This has been observed in studies involving brain, breast, prostate, pancreatic, colon, liver, and several other cancers.

2. Slowing Tumor Growth

Cancer develops when cells divide faster than the body can regulate.

Researchers have found that cannabinoids may interfere with several pathways involved in cell division, causing some tumors in laboratory models to grow more slowly.

These effects appear to involve changes in cell-cycle regulation, oxidative stress, and intracellular signaling pathways such as PI3K/Akt and MAPK.

3. Preventing New Blood Vessel Formation

Tumors need a blood supply to continue growing.

Some laboratory studies suggest cannabinoids reduce the production of vascular endothelial growth factor (VEGF) and other molecules involved in angiogenesis—the process of forming new blood vessels.

With fewer blood vessels, tumors in animal models sometimes grow more slowly.

4. Reducing Metastatic Potential

Metastasis occurs when cancer spreads to other parts of the body.

Experimental studies have shown cannabinoids can alter proteins involved in cancer cell movement, invasion, and adhesion. In some animal models, this reduced the ability of cancer cells to spread.

Whether these findings translate into meaningful reductions in metastasis in people remains unknown.

5. Influencing the Immune System

The endocannabinoid system helps regulate immune activity.

Cannabinoids interact primarily with CB1 and CB2 receptors, but they also affect numerous other signaling pathways involved in inflammation and immune regulation.

Researchers continue investigating whether these effects might help create an environment less favorable for tumor growth while recognizing that immune effects can be complex and may differ depending on the cancer type and treatment.

What About Cholangiocarcinoma?

Research specifically examining cannabinoids and bile duct cancer is limited but growing.

Several laboratory studies have reported that cannabinoids can reduce the growth of cholangiocarcinoma cells and increase cancer cell death under controlled experimental conditions.

These findings are encouraging because they suggest bile duct cancer cells possess biological pathways that respond to cannabinoid signaling.

However, these experiments were performed in cell cultures or animals—not in patients. We do not yet know whether the same effects occur in people using RSO. If you are navigating cancer or another serious illness, Mercy Leaf’s Serious Illness & Cancer resources may also be helpful.

Why Doesn't This Mean RSO Cures Cancer?

There are several reasons laboratory success doesn't automatically translate into human success.

Laboratory studies often expose cancer cells directly to cannabinoid concentrations that may be difficult or impossible to achieve safely in the human body. Human cancers are also influenced by the immune system, blood supply, genetics, surrounding tissues, and many other factors that cannot be fully replicated in a laboratory dish.

In addition, RSO is not a standardized medication. Its cannabinoid and terpene content varies depending on the cannabis strain, extraction method, and preparation, making it difficult to compare results between products.

Could RSO Be Part of Future Cancer Therapy?

Possibly.

Scientists around the world are studying cannabinoids as potential adjuncts to conventional cancer treatment. Early research is exploring whether cannabinoids might:

• Enhance the effectiveness of certain chemotherapy drugs.
• Increase the sensitivity of some tumors to radiation.
• Help overcome treatment resistance in specific cancers.
• Reduce inflammation within the tumor environment.
• Improve symptom control and quality of life during treatment.

These possibilities are promising, but they remain under investigation.